1. Home
  2. DNLI vs SAND Comparison

DNLI vs SAND Comparison

Compare DNLI & SAND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DNLI
  • SAND
  • Stock Information
  • Founded
  • DNLI 2013
  • SAND 2007
  • Country
  • DNLI United States
  • SAND Canada
  • Employees
  • DNLI N/A
  • SAND N/A
  • Industry
  • DNLI Biotechnology: Biological Products (No Diagnostic Substances)
  • SAND
  • Sector
  • DNLI Health Care
  • SAND
  • Exchange
  • DNLI Nasdaq
  • SAND NYSE
  • Market Cap
  • DNLI 2.1B
  • SAND 2.4B
  • IPO Year
  • DNLI 2017
  • SAND N/A
  • Fundamental
  • Price
  • DNLI $13.89
  • SAND $9.14
  • Analyst Decision
  • DNLI Strong Buy
  • SAND Buy
  • Analyst Count
  • DNLI 15
  • SAND 4
  • Target Price
  • DNLI $33.85
  • SAND $9.13
  • AVG Volume (30 Days)
  • DNLI 1.6M
  • SAND 5.1M
  • Earning Date
  • DNLI 07-31-2025
  • SAND 07-31-2025
  • Dividend Yield
  • DNLI N/A
  • SAND 0.62%
  • EPS Growth
  • DNLI N/A
  • SAND 32.83
  • EPS
  • DNLI N/A
  • SAND 0.10
  • Revenue
  • DNLI N/A
  • SAND $183,537,000.00
  • Revenue This Year
  • DNLI N/A
  • SAND $17.55
  • Revenue Next Year
  • DNLI $335.74
  • SAND $10.62
  • P/E Ratio
  • DNLI N/A
  • SAND $93.63
  • Revenue Growth
  • DNLI N/A
  • SAND 2.84
  • 52 Week Low
  • DNLI $10.57
  • SAND $4.92
  • 52 Week High
  • DNLI $33.33
  • SAND $9.68
  • Technical
  • Relative Strength Index (RSI)
  • DNLI 45.02
  • SAND 55.95
  • Support Level
  • DNLI $14.19
  • SAND $9.12
  • Resistance Level
  • DNLI $14.88
  • SAND $9.38
  • Average True Range (ATR)
  • DNLI 0.77
  • SAND 0.23
  • MACD
  • DNLI -0.03
  • SAND -0.04
  • Stochastic Oscillator
  • DNLI 34.55
  • SAND 35.12

About DNLI Denali Therapeutics Inc.

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.

About SAND SANDSTORM GOLD LIMITED

Sandstorm Gold Ltd provides financing to companies engaged in gold mining through the gold stream and royalty. Geographically, the company has operational footprints in North America, South & Central America, Africa, and Asia & Australia. The firm's royalties include Hod Maden, Santa Elena, Chapada, Platreef, Greenstone, and Cerro Moro.

Share on Social Networks: